2024

Psychological Morbidity and Care
Polomeni A, Scherwath A
2024. The EBMT Handbook. Sureda A, Corbacioglu S, Greco R, Kröger N, Carreras E (eds.). 8. ed. Cham, Switzerland: Springer, Cham, 265-271.

2023

Cognitive Deficits in Executive and Language Functions Predict Postoperative Delirium
Olotu C, Lebherz L, Ascone L, Scherwath A, Kühn S, Härter M, Kiefmann R
J CARDIOTHOR VASC AN. 2023;37(12):2552-2560.

2022

The effect of delirium preventive measures on the occurrence of postoperative cognitive dysfunction in older adults undergoing cardiovascular surgery. The DelPOCD randomised controlled trial
Olotu C, Ascone L, Wiede J, Manthey J, Kuehn S, Scherwath A, Kiefmann R
J CLIN ANESTH. 2022;78:.

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network
Perovic V, Sabol I, Grce M, Inngjerdingen M, Pulanic D, Peric Z, Peczynski C, Polge E, Koenecke C, Dickinson A, Greinix H, Basak G, Penack O, Scherwath A, Barata A, Olivieri A, Lawitschka A, Mensah-Glanowska P, Andrikovics H, Schoemans H, Wolff D
BONE MARROW TRANSPL. 2022;57(9):1458-1460.

2021

Neurocognitive dysfunction
Buchbinder D, Scherwath A
2021. Blood and Marrow Transplantation Long Term Management. Savani B, Tichelli A (eds.). 2. ed. Hoboken, NJ: Wiley-Blackwell, 312-329.

2020

Systematic Review of Patient-Reported Outcome Measures in Graft-versus-Host Disease
Kilgour J, Wali G, Gibbons E, Scherwath A, Barata Badiella A, Peniket A, Schoemans H, Matin R
BIOL BLOOD MARROW TR. 2020;26(5):e113-e127.

2018

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT
Buchbinder D, Kelly D, Duarte R, Auletta J, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah A, Ahmed I, Atsuta Y, Basak G, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale R, Galvin J, Hamadani M, Hayashi R, Adekola K, Law J, Lee C, Liesveld J, Malone A, Nagler A, Naik S, Nishihori T, Parsons S, Scherwath A, Schofield H, Soiffer R, Szer J, Twist I, Warwick A, Wirk B, Yi J, Battiwalla M, Flowers M, Savani B, Shaw B
BONE MARROW TRANSPL. 2018;53(5):535-555.

Return to Work in Patients with Hematological Cancers 1 Year after Treatment: A Prospective Longitudinal Study
Hartung T, Sautier L, Scherwath A, Sturm K, Kröger N, Koch U, Mehnert A
ONCOL RES TREAT. 2018;41(11):697-701.

Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation
Kelly D, Buchbinder D, Duarte R, Auletta J, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah A, Ahmed I, Atsuta Y, Basak G, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale R, Galvin J, Hamadani M, Hayashi R, Adekola K, Law J, Lee C, Liesveld J, Malone A, Nagler A, Naik S, Nishihori T, Parsons S, Scherwath A, Schofield H, Soiffer R, Szer J, Twist I, Warwick A, Wirk B, Yi J, Battiwalla M, Flowers M, Savani B, Shaw B
BIOL BLOOD MARROW TR. 2018;24(2):228-241.

2017

Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT
Esser P, Kuba K, Mehnert A, Schwinn A, Schirmer L, Schulz-Kindermann F, Kruse M, Koch U, Zander A, Kröger N, Schilling G, Götze H, Scherwath A
BONE MARROW TRANSPL. 2017;52(5):753-758.

Stability and priority of symptoms and symptom clusters among allogeneic HSCT patients within a 5-year longitudinal study
Esser P, Kuba K, Scherwath A, Johansen C, Schwinn A, Schirmer L, Schulz-Kindermann F, Kruse M, Koch U, Zander A, Kröger N, Götze H, Mehnert A
J PAIN SYMPTOM MANAG. 2017;54(4):493-500.

Posttraumatic stress disorder symptomatology in the course of allogeneic HSCT: a prospective study
Esser P, Kuba K, Scherwath A, Schirmer L, Schulz-Kindermann F, Dinkel A, Balck F, Koch U, Kröger N, Götze H, Mehnert A
J CANCER SURVIV. 2017;11(2):203-210.

Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany
Kuba K, Esser P, Mehnert A, Johansen C, Schwinn A, Schirmer L, Schulz-Kindermann F, Kruse M, Koch U, Zander A, Kröger N, Götze H, Scherwath A
BONE MARROW TRANSPL. 2017;52(12):1651-1657.

Cancer-and-treatment-specific distress and its impact on posttraumatic stress in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT)
Kuba K, Esser P, Scherwath A, Schirmer L, Schulz-Kindermann F, Dinkel A, Balck F, Koch U, Kröger N, Götze H, Mehnert A
PSYCHO-ONCOLOGY. 2017;26(8):1164-1171.

2016

Kognitive Funktionsstörungen bei Krebserkrankungen und -therapien im Erwachsenenalter
Scherwath A
2016. Handbuch Psychoonkologie. Mehnert A, Koch U (eds.). 1. ed. Göttingen: Hogrefe, 353-364.

Neuropsychologische Beeinträchtigungen nach Stammzelltransplantation
Scherwath A
ONKOLOGE. 2016;22(7):493-498.

2015

Erfassung von Arbeitsengagement bei Patienten mit hämatologischen Malignomen: Die psychometrischen Eigenschaften der deutschen Version der Utrecht Work Engagement Scale 9 (UWES-9)
Sautier L, Scherwath A, Weis J, Sarkar S, Bosbach M, Schendel M, Ladehoff N, Koch U, Mehnert A
REHABILITATION. 2015;54(5):297-303.

Chemobrain – Kognitive Beeinträchtigungen bei Krebspatienten
Scherwath A
Onkologische Pflege. 2015;(1):52-56.

2014

Distress, anxiety and depression in patients with brain metastases before and after radiotherapy.
Cordes M, Scherwath A, Ahmad T, Cole A, Ernst G, Oppitz K, Lanfermann H, Bremer M, Steinmann D
BMC CANCER. 2014;14(731):.

Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT
Sarkar S, Scherwath A, Schirmer L, Schulz-Kindermann F, Neumann K, Kruse M, Dinkel A, Kunze S, Balck F, Kröger N, Koch U, Mehnert A
BONE MARROW TRANSPL. 2014;49(9):1217-22.

Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions
Schagen S, Klein M, Reijneveld J, Brain E, Deprez S, Joly F, Scherwath A, Schrauwen W, Wefel J
EJC Suppl. 2014;12(1):29-40.

2013

Self-reported cognitive outcomes in patients with brain metastases before and after radiation therapy
Cole A, Scherwath A, Ernst G, Lanfermann H, Bremer M, Steinmann D
INT J RADIAT ONCOL. 2013;87(4):705-12.

Psychische Belastung von Erwachsenen mit Neurofibromatose Typ 1: Eine Längsschnittstudie
Reichardt C, Scherwath A, Mautner V, Bullinger-Naber M, Petersen-Ewert C
PSYCHOTHER PSYCH MED. 2013;63(2):85-92.

Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study.
Scherwath A, Schirmer L, Kruse M, Ernst G, Eder M, Dinkel A, Kunze S, Balck F, Bornhäuser M, Ehninger G, Dolan K, Gramatzki M, Kolb H, Heußner P, Wilhelm H, Beelen D, Schulz-Kindermann F, Zander A, Koch-Gromus U, Mehnert A
PSYCHO-ONCOLOGY. 2013;22(7):1509-1516.

2011

Identifying children and adolescents with cognitive dysfunction following mild traumatic brain injury--preliminary findings on abbreviated neuropsychological testing.
Scherwath A, Sommerfeldt D, Bindt C, Nolte A, Boiger A, Koch-Gromus U, Petersen-Ewert C
BRAIN INJURY. 2011;25(4):401-408.

2009

Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation.
Rischer J, Scherwath A, Zander A, Koch U, Schulz-Kindermann F
BONE MARROW TRANSPL. 2009.

Stehen kognitive Funktionen im Zusammenhang mit Angst, Depression und Posttraumatischer Belastungsstörung bei Brustkrebspatientinnen nach onkologischer Behandlung?
Schirmer L, Mehnert A, Scherwath A, Schleimer B, Schulz-Kindermann F, Zander A, Koch-Gromus U
Z PSYCHIATR PSYCH PS. 2009;57(1):33-42.

2008

[Health care needs of children and adolescents with a traumatic brain injury]
Petersen-Ewert C, Scherwath A, Fink J, Koch-Gromus U
BUNDESGESUNDHEITSBLA. 2008;51(6):629-636.

Health-related quality of life and psychosocial consequences after mild traumatic brain injury in children and adolescents.
Petersen-Ewert C, Scherwath A, Fink J, Koch-Gromus U
BRAIN INJURY. 2008;22(3):215-221.

[Psychometric evaluation of a neuropsychological test battery measuring cognitive dysfunction in cancer patients--recommendations for a screening tool]
Scherwath A, Poppelreuter M, Weis J, Schulz-Kindermann F, Koch-Gromus U, Mehnert A
FORTSCHR NEUROL PSYC. 2008;76(10):583-593.

2007

The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen-Ewert C, Schulz-Kindermann F, Zander A, Koch-Gromus U
PATIENT EDUC COUNS. 2007;66(1):108-118.

Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies.
Schulz-Kindermann F, Mehnert A, Scherwath A, Schirmer L, Schleimer B, Zander A, Koch-Gromus U
BONE MARROW TRANSPL. 2007;39(12):789-799.

2006

Post-acute service utilisation and parental satisfaction with health care services after mild traumatic brain injury in children and adolescents.
Petersen C, Scherwath A, Kruithoff E, Koch U
BRAIN INJURY. 2006;20(3):321-326.

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects.
Scherwath A, Mehnert A, Schleimer B, Schirmer L, Fehlauer F, Kreienberg R, Metzner B, Thiel E, Zander A, Schulz-Kindermann F, Koch U
ANN ONCOL. 2006;17(3):415-423.

Letzte Aktualisierung aus dem FIS: 21.11.2024 - 02:59 Uhr